Phase 3
Completed N=471
Stimulant Abuser Groups to Engage in 12-Step
Drug Abuse
Source: ClinicalTrials.gov NCT00573183 ↗
Enrolled (actual)
471
Serious AEs
11.0%
Results posted
Jan 2014
Primary outcomePrimary: Days of Stimulant Use — 2.35; 2.13 days of stimulant use — p=<0.05
Summary
The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Days of Stimulant Use |
2.35; 2.13 | <0.05 sig |
| SECONDARY Attendance at 12-step Meetings |
12.01; 10.52 | <0.05 sig |
Eligibility Criteria
Inclusion Criteria
- seeking outpatient treatment for stimulant abuse or dependence
- current diagnosis of stimulant abuse or dependence
- willing to participate in the protocol
Exclusion Criteria
- not sufficiently medically or psychiatrically stable
- pending legal action that would inhibit their participation in the study
- in need of detoxification from opiates
Data sourced from ClinicalTrials.gov (NCT00573183). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.